John N Fink
Overview
Explore the profile of John N Fink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parsons M, Yogendrakumar V, Churilov L, Garcia-Esperon C, Campbell B, Russell M, et al.
Lancet Neurol
. 2024 Jun;
23(8):775-786.
PMID: 38880118
Background: Intravenous tenecteplase increases reperfusion in patients with salvageable brain tissue on perfusion imaging and might have advantages over alteplase as a thrombolytic for ischaemic stroke. We aimed to assess...
2.
Warach S, Ranta A, Kim J, Song S, Wallace A, Beharry J, et al.
JAMA Neurol
. 2023 May;
80(7):732-738.
PMID: 37252708
Importance: Symptomatic intracranial hemorrhage (sICH) is a serious complication of stroke thrombolytic therapy. Many stroke centers have adopted 0.25-mg/kg tenecteplase instead of alteplase for stroke thrombolysis based on evidence from...
3.
Dunphy H, Garcia-Esperon C, Hong J, Manoczki C, Wilson D, Chew B, et al.
Eur Stroke J
. 2023 Apr;
8(1):191-198.
PMID: 37021178
Introduction: The very elderly (⩾80 years) are under-represented in randomised endovascular thrombectomy (EVT) clinical trials for acute ischaemic stroke. Rates of independent outcome in this group are generally lower than...
4.
Denison H, Corbin M, Douwes J, Thompson S, Harwood M, Davis A, et al.
Int J Stroke
. 2023 Mar;
18(6):663-671.
PMID: 36872640
Background: Ethnic differences in post-stroke outcomes have been largely attributed to biological and socioeconomic characteristics resulting in differential risk factor profiles and stroke subtypes, but evidence is mixed. Aims: This...
5.
Harwood M, Ranta A, Thompson S, Ranta S, Brewer K, Gommans J, et al.
N Z Med J
. 2022 Jun;
135(1556):81-93.
PMID: 35728251
Aim: The aim of this study was to explore the perspectives of people with stroke and their whānau on barriers to accessing best practice care across Aotearoa, and to brainstorm...
6.
Thompson S, Barber P, Gommans J, Cadilhac D, Davis A, Fink J, et al.
Neurology
. 2022 May;
99(4):e414-e426.
PMID: 35623890
Background And Objectives: International evidence shows that patients treated at nonurban hospitals experience poorer access to key stroke interventions. Evidence for whether this results in poorer outcomes is conflicting and...
7.
Thompson S, Barber P, Gommans J, Cadilhac D, Davis A, Fink J, et al.
Lancet Reg Health West Pac
. 2022 Jan;
20:100358.
PMID: 35036976
Background: Ethnic inequities in stroke care access have been reported internationally but the impact on outcomes remains unclear. In New Zealand, data on ethnic stroke inequities and resultant effects on...
8.
Zhong C, Beharry J, Salazar D, Smith K, Withington S, Campbell B, et al.
Stroke
. 2021 Feb;
52(3):1087-1090.
PMID: 33588597
Background And Purpose: In ischemic stroke, intravenous tenecteplase is noninferior to alteplase in selected patients and has some practical advantages. Several stroke centers in New Zealand changed to routine off-label...
9.
Wu T, Myall D, Palmer D, Beharry J, Lim J, Mason D, et al.
Neurology
. 2020 Dec;
96(4):171-174.
PMID: 33310879
No abstract available.
10.
Senadeera S, Palmer D, Keenan R, Beharry J, Lim J, Hurrell M, et al.
Stroke
. 2020 Nov;
51(12):3760-3764.
PMID: 33161849
Background And Purpose: Left atrial appendage (LAA) is the likely embolic source in atrial fibrillation (AF)-related cardioembolic strokes. We sought to determine the prevalence of LAA thrombus on hyperacute stroke...